Account
Jollywell appoints GenY Medium to handle digital duties
NEW DELHI: GenY Medium has been appointed as the strategic digital partner of Indian nutraceutical startup, Jollywell. The account was won following a competitive multi-agency pitch.
The homegrown brand addresses India’s growing need for organic, plant based and clean nutritional dietary supplements which help its consumers make healthier lifestyle choices.
In a remit encompassing all of its strengths, GenY Medium will assume the role of a strategic partner right from the product development stage, advising on the target consumers and markets to implementing technology tools and various marketing tactics. GenY will also be responsible for a full-funnel management from designing its content to brand communications to performance marketing for customer acquisition and building a base of loyal users. They will ultimately aid Jollywell in its efforts to carve out a niche as an ethical and sustainable nutraceutical brand.
GenY Medium co-founder and CEO Yashwant Kumar said, "We are excited about our association with Jollywell, the opportunity to work with them will further strengthen our foothold in the healthcare segment. With our tailor-made practices and expertise in technology and marketing, our focus will be to win on each of the key milestones for Jollywell right from the product development stage to amplifying the brand visibility”
Jollywell co-founders Sujeesh and Bindu added, “We have worked with multiple digital marketing agencies in the past, but they were either creative focused or would execute our ideas. GenY Medium came across as an agency with a sound strategic approach and focus on ROI. In our interactions with the team before we signed up, we realized they had both the depth and breadth of experience that we need to make Jollywell succeed. We are confident, with GenY as our partner, we will meet our business goals.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
